Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia.
D000017:ABO Blood-Group System; D000208:Acute Disease; D001787:Blood Group Incompatibility; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002648:Child; D002678:Chimera; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006087:Graft vs Host Reaction; D006648:Histocompatibility; D006801:Humans; D007938:Leukemia / Q000532:radiotherapy / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D013866:Thioguanine / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000017:ABO Blood-Group System; D009607:Nitrosourea Compounds; D003561:Cytarabine; D003520:Cyclophosphamide; D013866:Thioguanine; D008727:Methotrexate